Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients? Formal Study

NCT ID: NCT00550251

Last Updated: 2018-05-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

58 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-07-31

Study Completion Date

2018-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pilot study completed - power calculation performed. Now formal double blind randomized study comparing active with placebo wristbands for nausea in palliative care patients to be carried out.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Terminally ill hospice in-patients suffering with nausea will be randomized to active or placebo acupressure bands. The study will last 3 days and they will be allowed to continue regular or have PRN anti-emetics during the study.

Assessors and patients will both be blinded to whether they patients are receiving active or placebo bands.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nausea Vomiting

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acupressure Bands

Elasticated wrist bands with active bead pressing on Pericardium 6 acupressure points bilaterally.

Group Type ACTIVE_COMPARATOR

Acupressure Wrist Bands (Sea-Bands)

Intervention Type DEVICE

Elasticated wrist bands with active bead pressing on Pericardium 6 acupressure points bilaterally.

Placebo

Elasticated wrist bands without active bead.

Group Type PLACEBO_COMPARATOR

Placebo wristbands

Intervention Type DEVICE

Elasticated wrist bands without active bead.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Acupressure Wrist Bands (Sea-Bands)

Elasticated wrist bands with active bead pressing on Pericardium 6 acupressure points bilaterally.

Intervention Type DEVICE

Placebo wristbands

Elasticated wrist bands without active bead.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Sea-Bands Seaband Placebo

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Have a diagnosis of advanced cancer with an estimated prognosis of less than 1 year but more than 3 days.
2. Describe their nausea as at least moderate on a Likert scale OR at have had at least one vomit per day for the last three days.
3. Have an underlying cause for their nausea which is thought to be irreversible OR the patient has made an autonomous choice not to proceed with treatment for any potentially reversible cause (for example surgery for obstruction or drainage of ascites).
4. Can be male or female patients but must be over the age of 18.
5. Have signed a consent form prior to entering the study.
6. If patients are taking corticosteroids the dosage should be stable for 3 days before and during the trial.
7. Be thought to be well enough to complete the 3 day trial.

Exclusion Criteria

1. Arm lymphoedema.
2. Weakness, fatigue or confusion sufficient that patient is unable to take part.
3. Previous history of acupuncture/acupressure for nausea or vomiting, or history of use of acupressure by a close relative.
4. History of Parkinsonism or Parkinsonism on examination.
5. Patients will not be enrolled if they are sharing a room with another patient taking part in the study.
6. Patients who are unable to read or comprehend the questionnaire or Visual Analogue Scale.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sue Ryder Care

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Paul Perkins

Consultant in Palliative Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paul Perkins, MB Bch MRCP

Role: STUDY_DIRECTOR

Sue Ryder Care Leckhampton Court Hospice

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sue Ryder Care Leckhampton Court Hospice

Cheltenham, Gloucestershire, United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Paul Perkins, MB BCh MRCP

Role: CONTACT

+44 1242 230199

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Paul Perkins, MB BCh MRCP

Role: primary

+441242230199

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SRC2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Multicenter Sous Vide Frostbite
NCT05280301 COMPLETED NA
Risk Factors for Exertional Heat Illness
NCT04979455 ACTIVE_NOT_RECRUITING